Cardiac Allograft Vasculopathy Is Abrogated by Anti-CD8 Monoclonal Antibody Therapy
- 1 October 1997
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 64 (4) , 1019-1025
- https://doi.org/10.1016/s0003-4975(97)00796-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Early development of accelerated graft coronary artery disease: Risk factors and courseJournal of the American College of Cardiology, 1996
- Cardiac allograft vasculopathy in partially inbred miniature swine. I. Time course, pathology, and dependence on immune mechanismsThe Journal of Thoracic and Cardiovascular Surgery, 1996
- EVIDENCE THAT RECIPIENT CD8+ T CELL DEPLETION DOES NOT ALTER DEVELOPMENT OF CHRONIC VASCULAR REJECTION IN A RAT HEART ALLOGRAFT MODELTransplantation, 1994
- Immune mechanisms of cardiac allograft vasculopathy: an updateTransplant Immunology, 1993
- Production of monoclonal antibodies reactive with polymorphic and monomorphic determinants of SLA class I gene productsImmunogenetics, 1991
- IN VIVO TREATMENT WITH ANTIPORCINE T CELL ANTIBODIESTransplantation, 1990
- LOCALIZATION OF CLASS II MHC ANTIGENS ON PORCINE RENAL VASCULAR ENDOTHELIUMTransplantation, 1984
- PATHOGENESIS AND PREVENTION OF GRAFT ARTERIOSCLEROSIS IN AN EXPERIMENTAL HEART TRANSPLANT MODELTransplantation, 1981
- TRANSPLANTATION IN MINIATURE SWINETransplantation, 1981
- TRANSPLANTATION IN MINIATURE SWINETransplantation, 1976